PulManage, Inc

PulManage, Inc is a startup offering a predictive mHealth platform for chronic lung disease. The company has identified a substantial market opportunity in respiratory care, with a global addressable market (TAM) of $300 billion. PulManage aims to address challenges in respiratory care, including accurate diagnosis, disease management, and access to real-time data trends for decentralized clinical trial data collection. The innovative platform enables remote respiratory biomarker collection and analysis, facilitating accurate diagnosis, remote monitoring, and forecasting changes in chronic respiratory conditions through data modeling. Founded in 2020 in the United States, the company aims to enhance patient outcomes and significantly reduce healthcare costs. With a focus on health care and medical devices, PulManage offers potential investors and partners a promising financial return.